Evidence map›Paper›PMID 29604965›Full record

ArticleCell calcium2018

Computational modeling of amylin-induced calcium dysregulation in rat ventricular cardiomyocytes.

Bradley D Stewart, Caitlin E Scott, Thomas P McCoy, Guo Yin, Florin Despa, Sanda Despa, Peter M Kekenes-Huskey

Open access · greenAbstract read
In one paragraph

Article in Cell calcium, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Bradley D StewartDepartment of Chemistry, University of Kentucky, 505 Rose St. Chemistry-Physics Building, Lexington, KY 40506, USA.
Caitlin E ScottDepartment of Chemistry, University of Kentucky, 505 Rose St. Chemistry-Physics Building, Lexington, KY 40506, USA.
Thomas P McCoyDepartment of Family & Community Nursing, University of North Carolina - Greensboro, 1008 Administration Dr. McIver Building, Greensboro, NC 27412, USA.
Guo YinDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, UK Medical Center, MN 150, Lexington, KY 40536, USA.
Florin DespaDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, UK Medical Center, MN 150, Lexington, KY 40536, USA.
Sanda DespaDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, UK Medical Center, MN 150, Lexington, KY 40536, USA. Electronic address: s.despa@uky.edu.
Peter M Kekenes-HuskeyDepartment of Chemistry, University of Kentucky, 505 Rose St. Chemistry-Physics Building, Lexington, KY 40506, USA. Electronic address: pkekeneshuskey@uky.edu.
University of Kentucky · USUniversity of Kentucky HealthCare · USUniversity of North Carolina at Greensboro · US

Funding

The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2012 to 2017
$13.7M
Mechanisms of cardiac Ca dysregulation and arrhythmias in ankyrin B deficiencyR01HL109501 · NHLBI · UNIVERSITY OF KENTUCKY · PI DESPA, SANDA · 2011 to 2015
$1.9M
Role of Systemic Amylin Dyshomeostasis in Alzheimer's DiseaseR01AG053999 · NIA · UNIVERSITY OF KENTUCKY · PI DESPA, FLORIN · 2016 to 2020
$1.9M
PROBING CELLULAR INTRACELLULAR CALCIUM SIGNALING AND SENSING THROUGH COMPUTATIONR35GM124977 · NIGMS · UNIVERSITY OF KENTUCKY · PI KEKENES-HUSKEY, PETER MICHAEL · 2017 to 2021
$1.8M
Hyperamylinemia in Diabetic Heart Disease: Mechanisms, Responses, and PreventionR01HL118474 · NHLBI · UNIVERSITY OF KENTUCKY · PI DESPA, FLORIN · 2013 to 2016
$1.5M
Monomeric G-proteins and Cardioprotection from Heart FailureR56HL131782 · NHLBI · UNIVERSITY OF KENTUCKY · PI ANDRES, DOUGLAS ALLEN, SATIN, JONATHAN · 2016 to 2016
$525k
NHLBI NIH HHS R01 HL109501NHLBI NIH HHS R01 HL118474NHLBI NIH HHS R56 HL131782NIA NIH HHS R01 AG053999NIGMS NIH HHS P20 GM103527NIGMS NIH HHS R35 GM124977
6 · The paper itself

Abstract

Hyperamylinemia is a condition that accompanies obesity and precedes type II diabetes, and it is characterized by above-normal blood levels of amylin, the pancreas-derived peptide. Human amylin oligomerizes easily and can deposit in the pancreas [1], brain [2], and heart [3], where they have been associated with calcium dysregulation. In the heart, accumulating evidence suggests that human amylin oligomers form moderately cation-selective [4,5] channels that embed in the cell sarcolemma (SL). The oligomers increase membrane conductance in a concentration-dependent manner [5], which is correlated with elevated cytosolic Ca

Indexed as

Models, BiologicalAnimalsCalciumCalcium SignalingHeart VentriclesHumansIonsIslet Amyloid PolypeptideMiceMyocytes, CardiacRatsRats, Sprague-DawleyRyanodine Receptor Calcium Release ChannelSarcolemmaCalciumIonsIslet Amyloid PolypeptideRyanodine Receptor Calcium Release ChannelAmylin Ca(2+) leakCa(2+) dysregulationCa(2+) transientsCardiomyocytesPre-diabetic rats

Identifiers

PMID29604965
PMCPMC5881945
OpenAlexW2607485704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.